Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 8.

Journal Article

Abrahamyan, S., Eberspaecher, B., Ambrosius, B., Hessler, N., Antony, G., Koenig, I. R., Hoshi, M. -M., Aly, L., Luessi, F., Groppa, S., Klotz, L., Meuth, S. G., Tackenberg, B., Stoppe, M., Bergh, F. Then, Tumani, H., Kuempfel, T., Stangel, M., Heesen, C., Wildemann, B., Paul, F., Bayas, A., Warnke, C., Weber, F., Linker, R. A., Ziemann, U., Zettl, U. K., Zipp, F., Wiendl, H., Hemmer, B., Gold, R., Salmen, A. and Ruprecht, K. (2018). Absence of Epstein-Barr virus seronegativity in a large cohort of patients with early multiple sclerosis. Mult. Scler. J., 24. S. 981 - 983. LONDON: SAGE PUBLICATIONS LTD. ISSN 1477-0970

Ambrosius, B., Hessler, N., Antony, G., Konig, I. R., Hoshi, M-M., Aly, L., Luessi, F., Groppa, S., Klotz, L., Meuth, S. G., Tackenberg, B., Stoppe, M., Bergh, F. Then, Tumani, H., Kuempfel, T., Stangel, M., Heesen, C., Wildemann, B., Paul, F., Bayas, A., Warnke, C., Weber, F., Linker, R. A., Ziemann, U., Zettl, U. K., Zipp, F., Wiendl, H., Hemmer, B., Gold, R. and Salmen, A. (2018). Changes of disease characteristics and disease-modifying treatment within one year in the National German MS cohort. Mult. Scler. J., 24. S. 554 - 557. LONDON: SAGE PUBLICATIONS LTD. ISSN 1477-0970

Frenken, P., Hartung, H-P., Olsson, T., Adams, O. and Warnke, C. (2017). Type 0 blood group associates with higher anti-JCV antibody levels. Mult. Scler. J., 23. S. 918 - 920. LONDON: SAGE PUBLICATIONS LTD. ISSN 1477-0970

Goereci, Y., Schweitzer, F., Wellstein, A., Silling, S., Borchmann, S., von Tresckow, B., Adams, O., Martin, R., Schlamann, M., Schroeter, M., Fink, G. R., Wattjes, M. P. and Warnke, C. (2020). Clearance of JC polyomavirus from cerebrospinal fluid following treatment with interleukin-2 and pembrolizumab in an individual with progressive multifocal leukoencephalopathy and no underlying immune deficiency syndrome. Eur. J. Neurol., 27 (11). S. 2375 - 2378. HOBOKEN: WILEY. ISSN 1468-1331

Huss, A., Otto, M., Tackenberg, B., Stangel, M., Aktas, O., Meuth, S., Gross, C. C., Bayas, A., Wildemann, B., Luessi, F., Seipelt, M., Puetz, M., Antony, G., Weber, F., Uhr, M., Bischof', F., Ruprecht, K., Buck, D., Retzlaff, N., Zettl, U. K., Haghikia, A., Lukas, C., Hartung, H. -P., Bergh, F. Then, Warnke, C., Zipp, F., Wiendl, H., Hemmer, B., Gold, R. and Tumani, H. (2018). Prospective multicenter validation of CSF protein biomarkers in patients with CIS and early MS. Mult. Scler. J., 24. S. 656 - 658. LONDON: SAGE PUBLICATIONS LTD. ISSN 1477-0970

Ladwig, A., Suh, J., Schweitzer, F., Roeth, P., Remke, G., Warnke, C., Schroeter, M., Izquierdo-Alvarez, E., Bonmann, E., Fink, G. R., Pallasch, C. and Lehmann, H. (2020). Alemtuzumab induces changes in the innate immune system in patients with relapsing-remitting multiple sclerosis. Mult. Scler. J., 26 (3_SUPPL). S. 259 - 260. LONDON: SAGE PUBLICATIONS LTD. ISSN 1477-0970

Schweitzer, F., Ladwig, A., Laurent, S., Schroeter, M., Goelz, S., Wieland, U., Silling, S. and Warnke, C. (2020). Is the gut a relevant reservoir for persistent jcpyv infection? Mult. Scler. J., 26 (3_SUPPL). S. 286 - 288. LONDON: SAGE PUBLICATIONS LTD. ISSN 1477-0970

Schweitzer, F., Laurent, S., Fink, G. R., Barnett, Michael H., Hartung, H. P. and Warnke, C. . Effects of disease-modifying therapy on peripheral leukocytes in patients with multiple sclerosis. J. Neurol.. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1459

This list was generated on Sun Mar 7 04:36:00 2021 CET.